USPTO Says Group Lacks Standing In Stem Cell Patent Appeal

Law360, New York (January 23, 2014, 5:33 PM EST) -- The U.S. Patent and Trademark Office told the Federal Circuit last week that parties without a "concrete" interest in a patent cannot appeal USPTO review decisions, urging the court to toss an appeal by a consumer group challenging the validity of a stem cell patent.

In an amicus brief filed Jan. 17 and made public Thursday, the agency noted that anyone can seek to have the validity of patents re-examined in USPTO proceedings, but argued that only those that have suffered some injury have standing under...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.